I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Irinotecan combined with 5-fluorouracil and leucovorin thir..:
Kang, Eun Joo
;
Im, Seock-Ah
;
Oh, Do-Youn
...
Gastric Cancer, Vol.16 No.4, pp.581-589. , 2020
Link:
https://hdl.handle.net/10371/173080
RT Journal T1
Irinotecan combined with 5-fluorouracil and leucovorin third-line chemotherapy after failure of fluoropyrimidine, platinum, and taxane in gastric cancer: treatment outcomes and a prognostic model to predict survival
UL https://suche.suub.uni-bremen.de/peid=base-ftseoulnuniv:oai:s-space.snu.ac.kr:10371_173080&Exemplar=1&LAN=DE A1 Kang, Eun Joo A1 Im, Seock-Ah A1 Oh, Do-Youn A1 Han, Sae-Won A1 Kim, Jin-Soo A1 Choi, In Sil A1 Kim, Jin Won A1 Kim, Yu Jung A1 Kim, Jee Hyun A1 Kim, Tae-You A1 Lee, Jong Seok A1 Bang, Yung-Jue A1 Lee, Keun-Wook PB Springer Verlag YR 2020 K1 RANDOMIZED PHASE-III K1 LOW-DOSE LEUCOVORIN K1 2ND-LINE CHEMOTHERAPY K1 COMBINATION CHEMOTHERAPY K1 SALVAGE CHEMOTHERAPY K1 BIWEEKLY IRINOTECAN K1 SUPPORTIVE CARE K1 TRIAL K1 THERAPY K1 PLUS K1 Gastric cancer K1 Third-line chemotherapy K1 Irinotecan K1 FOLFIRI K1 Prognostic factor JF Gastric Cancer, Vol.16 No.4, pp.581-589 LK http://dx.doi.org/https://hdl.handle.net/10371/173080 DO https://hdl.handle.net/10371/173080 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)